Neo Ivy Capital Management

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1727783 NEW YORK, NY

Position in BMRN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,449,123

+$2,160,311 QoQ

Shares Held

43,355

+725.2% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.65%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Neo Ivy Capital Management holds $22,354,354 across 16 Biotechnology names. BMRN ranks #3 (11.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DYN	Dyne Therapeutics, Inc.	168,753	$3,059,491
2	FOLD	AMICUS THERAPEUTICS, INC.	186,172	$2,692,047
3	BMRN	Biomarin Pharmaceutical Inc This page	43,355	$2,449,123
4	KYMR	Kymera Therapeutics, Inc.	27,033	$2,251,578
5	TGTX	Tg Therapeutics, Inc.	60,833	$2,020,872
6	ADMA	Adma Biologics, Inc.	199,687	$1,799,179
7	ROIV	Roivant Sciences Ltd.	64,106	$1,775,736
8	RARE	Ultragenyx Pharmaceutical Inc.	73,601	$1,541,940

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,449,123	43,355	+725.2%	Shares	Sole	2026-05-15
2025-06-30	$288,812	5,254	-79.1%	Shares	Sole	2025-08-12
2025-03-31	$1,773,470	25,088	+19.4%	Shares	Sole	2025-05-06
2024-09-30	$1,477,495	21,020	+2225.2%	Shares	Sole	2024-11-18
2024-06-30	$74,426	904	+13.3%	Shares	Sole	2024-07-19
2022-09-30	$67,646	798	+7.4%	Shares	Sole	2022-11-16
2022-06-30	$61,572	743	-28.8%	Shares	Sole	2022-08-16
2021-09-30	$80,690	1,044	+106.7%	Shares	Sole	2021-11-16
2021-03-31	$38,132	505	-26.5%	Shares	Sole	2021-10-07
2020-12-31	$60,243	687	-34.2%	Shares	Sole	2021-02-16
2020-06-30	$128,766	1,044	+193.3%	Shares	Sole	2020-08-17
2020-03-31	$30,082	356	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.